byiShook Opinion
Nov 22, 2024 - 13:50
AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep. The post AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback appeared first on Investor's Business Daily.
AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep.
The post AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback appeared first on Investor's Business Daily.